Recombinant Human AG-3 (C-6His)

Produktübersicht

• Artikelname: Recombinant Human AG-3 (C-6His)
• Artikelnummer: EBT-EPT221
• Hersteller Artikelnummer: EPT221
• Alternativnummer: EBT-EPT221-10
• Hersteller: ELK Biotechnology
• Kategorie: Proteine/Peptide
• Alternative Synonym: Anterior Gradient Protein 3 Homolog, AG-3, AG3, hAG-3, Breast Cancer Membrane Protein 11, AGR3, BCMP11

Produktbeschreibung

Recombinant Human Anterior Gradient Protein 3 Homolog is produced by our Mammalian expression system and the target gene encoding Ile22-Leu166 is expressed with a 6His tag at the C-terminus.

Produkteigenschaften

• Molekulargewicht: Molecular weight: 18.04 KDa. Apparent molecular weight: 16 KDa, reducing conditions
• UniProt: Q8TD06
• Reinheit: Greater than 95% as determined by reducing SDS-PAGE.

Anwendungsbeschreibung

• Anwendungsbeschreibung: Redissolve: Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100µg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.. Endotoxin: Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. Background: Anterior Gradient Protein 2(AG-2) and Anterior Gradient Protein 3 (AG-3) are human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan (hAG-3 protein). AG-3 could serve as a prognostic marker for survival in patients with low grade and high grade serous ovarian carcinomas